APO Research
Talk to an analyst

APO RESEARCH · REPORT

Combination Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Combination Vaccine Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchCombination Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Combination Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Combination Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Combination Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Combination Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Combination Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Combination Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Combination Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Combination Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Combination Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Combination Vaccine include GSK, Merck, Pfizer, Serum Institute of India, Sanofi Pasteur MSD, Sanofi Pasteur, CNBG and Biokangtai, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Combination Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Combination Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Combination Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Combination Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Combination Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Combination Vaccine sales, projected growth trends, production technology, application and end-user industry.

Combination Vaccine Segment by Company

GSK

Merck

Pfizer

Serum Institute of India

Sanofi Pasteur MSD

Sanofi Pasteur

CNBG

Biokangtai

Combination Vaccine Segment by Type

5 Combination

4 Combination

3 Combination

Other

Combination Vaccine Segment by Application

Adults

Children

Combination Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Combination Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Combination Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Combination Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Combination Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Combination Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Combination Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Combination Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 Combination Major Manufacturers Table 3. 4 Combination Major Manufacturers Table 4. 3 Combination Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Combination Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adults Major Manufacturers Table 8. Children Major Manufacturers Table 9. Combination Vaccine Industry Trends Table 10. Combination Vaccine Industry Drivers Table 11. Combination Vaccine Industry Opportunities and Challenges Table 12. Combination Vaccine Industry Restraints Table 13. Global Combination Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Combination Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Combination Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Combination Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Combination Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Combination Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Combination Vaccine Sales by Region (2021-2026) & (k units) Table 20. Global Combination Vaccine Sales by Region (2027-2032) & (k units) Table 21. Global Combination Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Combination Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Combination Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Combination Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Combination Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Combination Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Combination Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Combination Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Combination Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Combination Vaccine Manufacturers, Product Type & Application Table 31. Global Combination Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Combination Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Combination Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Combination Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Combination Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Combination Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Combination Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Combination Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Combination Vaccine Sales by Type (2021-2026) & (k units) Table 41. Global Combination Vaccine Sales by Type (2027-2032) & (k units) Table 42. Global Combination Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Combination Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Combination Vaccine Price by Type (2021-2026) & (US$/unit) Table 45. Global Combination Vaccine Price by Type (2027-2032) & (US$/unit) Table 46. Global Combination Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Combination Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Combination Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Combination Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Combination Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Combination Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Combination Vaccine Sales by Application (2021-2026) & (k units) Table 53. Global Combination Vaccine Sales by Application (2027-2032) & (k units) Table 54. Global Combination Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Combination Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Combination Vaccine Price by Application (2021-2026) & (US$/unit) Table 57. Global Combination Vaccine Price by Application (2027-2032) & (US$/unit) Table 58. GSK Company Information Table 59. GSK Business Overview Table 60. GSK Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. GSK Combination Vaccine Product Portfolio Table 62. GSK Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Merck Combination Vaccine Product Portfolio Table 67. Merck Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Pfizer Combination Vaccine Product Portfolio Table 72. Pfizer Recent Development Table 73. Serum Institute of India Company Information Table 74. Serum Institute of India Business Overview Table 75. Serum Institute of India Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Serum Institute of India Combination Vaccine Product Portfolio Table 77. Serum Institute of India Recent Development Table 78. Sanofi Pasteur MSD Company Information Table 79. Sanofi Pasteur MSD Business Overview Table 80. Sanofi Pasteur MSD Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Pasteur MSD Combination Vaccine Product Portfolio Table 82. Sanofi Pasteur MSD Recent Development Table 83. Sanofi Pasteur Company Information Table 84. Sanofi Pasteur Business Overview Table 85. Sanofi Pasteur Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Sanofi Pasteur Combination Vaccine Product Portfolio Table 87. Sanofi Pasteur Recent Development Table 88. CNBG Company Information Table 89. CNBG Business Overview Table 90. CNBG Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. CNBG Combination Vaccine Product Portfolio Table 92. CNBG Recent Development Table 93. Biokangtai Company Information Table 94. Biokangtai Business Overview Table 95. Biokangtai Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Biokangtai Combination Vaccine Product Portfolio Table 97. Biokangtai Recent Development Table 98. North America Combination Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Combination Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Combination Vaccine Sales by Type (2021-2026) & (k units) Table 101. North America Combination Vaccine Sales by Type (2027-2032) & (k units) Table 102. North America Combination Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 103. North America Combination Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 104. North America Combination Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Combination Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Combination Vaccine Sales by Application (2021-2026) & (k units) Table 107. North America Combination Vaccine Sales by Application (2027-2032) & (k units) Table 108. North America Combination Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 109. North America Combination Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 110. North America Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Combination Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Combination Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Combination Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 114. North America Combination Vaccine Sales by Country (2021-2026) & (k units) Table 115. North America Combination Vaccine Sales by Country (2027-2032) & (k units) Table 116. North America Combination Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 117. North America Combination Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 118. United States Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Canada Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 120. Mexico Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 121. Europe Combination Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Combination Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Combination Vaccine Sales by Type (2021-2026) & (k units) Table 124. Europe Combination Vaccine Sales by Type (2027-2032) & (k units) Table 125. Europe Combination Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 126. Europe Combination Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 127. Europe Combination Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Combination Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Combination Vaccine Sales by Application (2021-2026) & (k units) Table 130. Europe Combination Vaccine Sales by Application (2027-2032) & (k units) Table 131. Europe Combination Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 132. Europe Combination Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 133. Europe Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Combination Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Combination Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Combination Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 137. Europe Combination Vaccine Sales by Country (2021-2026) & (k units) Table 138. Europe Combination Vaccine Sales by Country (2027-2032) & (k units) Table 139. Europe Combination Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 140. Europe Combination Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 141. Germany Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 142. France Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 143. U.K. Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Italy Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Russia Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 146. Spain Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Sweden Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 150. Poland Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 151. China Combination Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 152. China Combination Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 153. China Combination Vaccine Sales by Type (2021-2026) & (k units) Table 154. China Combination Vaccine Sales by Type (2027-2032) & (k units) Table 155. China Combination Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 156. China Combination Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 157. China Combination Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 158. China Combination Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 159. China Combination Vaccine Sales by Application (2021-2026) & (k units) Table 160. China Combination Vaccine Sales by Application (2027-2032) & (k units) Table 161. China Combination Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 162. China Combination Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 163. Asia Combination Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Combination Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Combination Vaccine Sales by Type (2021-2026) & (k units) Table 166. Asia Combination Vaccine Sales by Type (2027-2032) & (k units) Table 167. Asia Combination Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 168. Asia Combination Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 169. Asia Combination Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Combination Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Combination Vaccine Sales by Application (2021-2026) & (k units) Table 172. Asia Combination Vaccine Sales by Application (2027-2032) & (k units) Table 173. Asia Combination Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 174. Asia Combination Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 175. Asia Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Combination Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Combination Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Combination Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 179. Asia Combination Vaccine Sales by Country (2021-2026) & (k units) Table 180. Asia Combination Vaccine Sales by Country (2027-2032) & (k units) Table 181. Asia Combination Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 182. Asia Combination Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 183. Japan Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 184. South Korea Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 185. India Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Australia Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Combination Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Combination Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Combination Vaccine Sales by Type (2021-2026) & (k units) Table 192. SAMEA Combination Vaccine Sales by Type (2027-2032) & (k units) Table 193. SAMEA Combination Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 194. SAMEA Combination Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 195. SAMEA Combination Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Combination Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Combination Vaccine Sales by Application (2021-2026) & (k units) Table 198. SAMEA Combination Vaccine Sales by Application (2027-2032) & (k units) Table 199. SAMEA Combination Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 200. SAMEA Combination Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 201. SAMEA Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Combination Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Combination Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Combination Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 205. SAMEA Combination Vaccine Sales by Country (2021-2026) & (k units) Table 206. SAMEA Combination Vaccine Sales by Country (2027-2032) & (k units) Table 207. SAMEA Combination Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 208. SAMEA Combination Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 209. Brazil Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Argentina Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Chile Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Colombia Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Peru Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Israel Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 216. UAE Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Turkey Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Iran Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Egypt Combination Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Combination Vaccine Distributors List Table 223. Combination Vaccine Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Combination Vaccine Image Figure 2. Global Combination Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Combination Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 Combination Image Figure 5. 4 Combination Image Figure 6. 3 Combination Image Figure 7. Other Image Figure 8. Global Combination Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Combination Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adults Image Figure 11. Children Image Figure 12. Global Combination Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Combination Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Combination Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Combination Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Combination Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Combination Vaccine Sales (2021-2032) & (k units) Figure 18. Global Combination Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Combination Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Combination Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Europe Combination Vaccine Sales YoY (2021-2032) & (k units) Figure 22. China Combination Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Combination Vaccine Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Combination Vaccine Sales YoY (2021-2032) & (k units) Figure 25. Global Combination Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Combination Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Combination Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Combination Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Combination Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Combination Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Combination Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Combination Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Combination Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Combination Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Combination Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Combination Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Combination Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Combination Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Combination Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Combination Vaccine Sales Share by Type (2021-2032) Figure 42. North America Combination Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Combination Vaccine Sales Share by Application (2021-2032) Figure 44. North America Combination Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Combination Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Combination Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Combination Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Combination Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Combination Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Combination Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Combination Vaccine Sales Share by Country (2021-2032) Figure 52. China Combination Vaccine Revenue Share by Type (2021-2032) Figure 53. China Combination Vaccine Sales Share by Type (2021-2032) Figure 54. China Combination Vaccine Revenue Share by Application (2021-2032) Figure 55. China Combination Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Combination Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Combination Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Combination Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Combination Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Combination Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Combination Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Combination Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Combination Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Combination Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Combination Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Combination Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Combination Vaccine Sales Share by Country (2021-2032) Figure 68. Combination Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Combination Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5 Combination
  • 4 Combination
  • 3 Combination
  • Other
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Merck
  • Pfizer
  • Serum Institute of India
  • Sanofi Pasteur MSD
  • Sanofi Pasteur
  • CNBG
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Combination Vaccine Market by Type
  3. 1.2.1 Global Combination Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 Combination
  5. 1.2.3 4 Combination
  6. 1.2.4 3 Combination
  7. 1.2.5 Other
  8. 1.3 Combination Vaccine Market by Application
  9. 1.3.1 Global Combination Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adults
  11. 1.3.3 Children
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Combination Vaccine Market Dynamics
  1. 2.1 Combination Vaccine Industry Trends
  2. 2.2 Combination Vaccine Industry Drivers
  3. 2.3 Combination Vaccine Industry Opportunities and Challenges
  4. 2.4 Combination Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Combination Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Combination Vaccine Revenue by Region
  3. 3.2.1 Global Combination Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Combination Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Combination Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Combination Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Combination Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Combination Vaccine Sales by Region
  9. 3.4.1 Global Combination Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Combination Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Combination Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Combination Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Combination Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Combination Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Combination Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Combination Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Combination Vaccine Sales by Manufacturers
  6. 4.2.1 Global Combination Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Combination Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Combination Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Combination Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Combination Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Combination Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Combination Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Combination Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Combination Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Combination Vaccine Tier 1, Tier 2, and Tier 3
5 Combination Vaccine Market by Type
  1. 5.1 Global Combination Vaccine Revenue by Type
  2. 5.1.1 Global Combination Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Combination Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Combination Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Combination Vaccine Sales by Type
  6. 5.2.1 Global Combination Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Combination Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Combination Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Combination Vaccine Price by Type
6 Combination Vaccine Market by Application
  1. 6.1 Global Combination Vaccine Revenue by Application
  2. 6.1.1 Global Combination Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Combination Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Combination Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Combination Vaccine Sales by Application
  6. 6.2.1 Global Combination Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Combination Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Combination Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Combination Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Combination Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Combination Vaccine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Combination Vaccine Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Serum Institute of India
  20. 7.4.1 Serum Institute of India Company Information
  21. 7.4.2 Serum Institute of India Business Overview
  22. 7.4.3 Serum Institute of India Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Serum Institute of India Combination Vaccine Product Portfolio
  24. 7.4.5 Serum Institute of India Recent Developments
  25. 7.5 Sanofi Pasteur MSD
  26. 7.5.1 Sanofi Pasteur MSD Company Information
  27. 7.5.2 Sanofi Pasteur MSD Business Overview
  28. 7.5.3 Sanofi Pasteur MSD Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Pasteur MSD Combination Vaccine Product Portfolio
  30. 7.5.5 Sanofi Pasteur MSD Recent Developments
  31. 7.6 Sanofi Pasteur
  32. 7.6.1 Sanofi Pasteur Company Information
  33. 7.6.2 Sanofi Pasteur Business Overview
  34. 7.6.3 Sanofi Pasteur Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Pasteur Combination Vaccine Product Portfolio
  36. 7.6.5 Sanofi Pasteur Recent Developments
  37. 7.7 CNBG
  38. 7.7.1 CNBG Company Information
  39. 7.7.2 CNBG Business Overview
  40. 7.7.3 CNBG Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CNBG Combination Vaccine Product Portfolio
  42. 7.7.5 CNBG Recent Developments
  43. 7.8 Biokangtai
  44. 7.8.1 Biokangtai Company Information
  45. 7.8.2 Biokangtai Business Overview
  46. 7.8.3 Biokangtai Combination Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biokangtai Combination Vaccine Product Portfolio
  48. 7.8.5 Biokangtai Recent Developments
8 North America
  1. 8.1 North America Combination Vaccine Market Size by Type
  2. 8.1.1 North America Combination Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Combination Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Combination Vaccine Price by Type (2021-2032)
  5. 8.2 North America Combination Vaccine Market Size by Application
  6. 8.2.1 North America Combination Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Combination Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Combination Vaccine Price by Application (2021-2032)
  9. 8.3 North America Combination Vaccine Market Size by Country
  10. 8.3.1 North America Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Combination Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Combination Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Combination Vaccine Market Size by Type
  2. 9.1.1 Europe Combination Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Combination Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Combination Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Combination Vaccine Market Size by Application
  6. 9.2.1 Europe Combination Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Combination Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Combination Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Combination Vaccine Market Size by Country
  10. 9.3.1 Europe Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Combination Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Combination Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Combination Vaccine Market Size by Type
  2. 10.1.1 China Combination Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Combination Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Combination Vaccine Price by Type (2021-2032)
  5. 10.2 China Combination Vaccine Market Size by Application
  6. 10.2.1 China Combination Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Combination Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Combination Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Combination Vaccine Market Size by Type
  2. 11.1.1 Asia Combination Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Combination Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Combination Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Combination Vaccine Market Size by Application
  6. 11.2.1 Asia Combination Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Combination Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Combination Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Combination Vaccine Market Size by Country
  10. 11.3.1 Asia Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Combination Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Combination Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Combination Vaccine Market Size by Type
  2. 12.1.1 SAMEA Combination Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Combination Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Combination Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Combination Vaccine Market Size by Application
  6. 12.2.1 SAMEA Combination Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Combination Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Combination Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Combination Vaccine Market Size by Country
  10. 12.3.1 SAMEA Combination Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Combination Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Combination Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Combination Vaccine Value Chain Analysis
  2. 13.1.1 Combination Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Combination Vaccine Production Mode & Process
  6. 13.2 Combination Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Combination Vaccine Distributors
  9. 13.2.3 Combination Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst